M. HENRY WILLIAMS Jr., M.D.
Experience with beclomethasone dipropionate during the past 5 years has confirmed and extended the original observation that it is an effective, topically active corticosteroid of great value in treating asthma. Most steroid-dependent asthmatic patients can be successfully controlled with the drug, at least most of the time, and the therapeutic effect is dose dependent. Although high doses may be associated with some adrenal suppression such doses do not cause systemic symptoms, and side effects are of little consequence. It is important that patients treated with steroid aerosols continue to receive other effective therapeutic agents, notably adrenergic drugs, particularly by aerosol, and theophylline compounds; that they learn how to inhale the aerosol properly; and, most important, that they promptly start taking oral steroids when they experience an exacerbation of asthma.
Learn more about subscription options.
Register Now for a free account.
WILLIAMS MH. Drugs Five Years Later: Beclomethasone Dipropionate. Ann Intern Med. 1981;95:464–467. doi: 10.7326/0003-4819-95-4-464
Download citation file:
Published: Ann Intern Med. 1981;95(4):464-467.
Adrenal Disorders, Asthma, Endocrine and Metabolism, Pulmonary/Critical Care.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only